Updated Jul 16, 2026
Nichols William Garrett is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $74K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-07-28 | CADL | Candel Therapeutics, Inc. | S — Open-market sale | 937 | $6.98 | $7K |
| 2025-07-28 | CADL | Candel Therapeutics, Inc. | M — Option exercise | 937 | $1.29 | $1K |
| 2025-06-30 | CADL | Candel Therapeutics, Inc. | S — Open-market sale | 781 | $5.04 | $4K |
| 2025-06-30 | CADL | Candel Therapeutics, Inc. | M — Option exercise | 781 | $1.29 | $1K |
| 2024-12-03 | CADL | Candel Therapeutics, Inc. | S — Open-market sale | 13.9K | $4.56 | $63K |
Nichols William Garrett is a corporate insider — currently tracked as Insider. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($74K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Nichols William Garrett profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.